Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Campbell, California.
Frequently asked questions
What sector does SEMLER SCIENTIFIC DL-001 (6FA) operate in?
SEMLER SCIENTIFIC DL-001 belongs to the Healthcare sector and operates in the industry.
What is SEMLER SCIENTIFIC DL-001 (6FA) current stock price?
As of the latest data, SEMLER SCIENTIFIC DL-001 stock price is €17.80, with a previous close of €17.80.
What is SEMLER SCIENTIFIC DL-001 (6FA) current market capitalization?
SEMLER SCIENTIFIC DL-001 market cap is approximately 272.07 million.
What is SEMLER SCIENTIFIC DL-001 (6FA) Earnings Per Share (EPS)?
The trailing EPS is €4.45.
What is SEMLER SCIENTIFIC DL-001 (6FA) Price-to-Earnings (P/E) ratio?
SEMLER SCIENTIFIC DL-001 current P/E ratio is 4.
Does SEMLER SCIENTIFIC DL-001 (6FA) pay dividends?
No. SEMLER SCIENTIFIC DL-001 does not pay a dividend.
When is SEMLER SCIENTIFIC DL-001 (6FA) next earnings report?
SEMLER SCIENTIFIC DL-001 is expected to release its next earnings report on September 30, 2026.
What is SEMLER SCIENTIFIC DL-001 (6FA) beta (volatility) score?
SEMLER SCIENTIFIC DL-001 has a beta of 1.240, suggesting it is more volatile than the market.
